GlassScriptPhysician profile
Zhanat Colotti
NPI 1194205252
$2,875.35
in general payments reported to CMS, 2019-2025
16 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $615 · 2023: $751 · 2024: $1,194 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,161 · Education: $99.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,161.21 |
| Education | $99.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $921.99 | 2022-2024 | |
| Incyte Corporation | $492.22 | 2022-2024 | Opzelura |
| Arcutis Biotherapeutics, INC. | $384.19 | 2023-2025 | Zoryve |
| Botanix Sb INC | $229.00 | 2025 | Sofdra |
| Dermavant Sciences, INC. | $220.26 | 2023-2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $146.19 | 2024 | Dupixent |
| Sun Pharmaceutical Industries INC. | $105.90 | 2024 | |
| Amgen INC. | $86.35 | 2023-2024 | Otezla |
| Verrica Pharmaceuticals INC. | $71.78 | 2023-2024 | Ycanth |
| Lilly USA, LLC | $47.27 | 2024 | Olumiant |
| Pfizer INC. | $43.22 | 2023-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.36 | 2022 | |
| Janssen Biotech, INC. | $32.09 | 2023-2024 | Tremfya, Simponi Aria, Stelara |
| E.R. Squibb & Sons, L.L.C. | $26.10 | 2024 | Sotyktu |
| Galderma Laboratories, L.P. | $17.58 | 2025 | Aklief |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $12.85 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zhanat Colotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.